The report forecast global ALK Positive Lung Cancer Treatment market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively."
The report demonstrates detail coverage of ALK Positive Lung Cancer Treatment industry and main market trends.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares of the leading ALK Positive Lung Cancer Treatment by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global ALK Positive Lung Cancer Treatment market discussed. Overall, this report covers the historical situation, present status and the future prospects of the global ALK Positive Lung Cancer Treatment market for 2016-2026.
Moreover,the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to over 100 countries and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard,while the online market increase. Fortunately, with the development of vaccine and other effort by global governments and orgnizations, the nagetive impact of COVID-19 is excepted to subside and the global ecnomy is excepted to recover.
Studying and analyzing the impact of Coronavirus COVID-19 on the ALK Positive Lung Cancer Treatment industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Crizotinib
Alectinib
Ceritinib
Brigatinib
Other
Market Segment by Product Application
Hospital
Clinics
Other
Finally, the report provides detailed profile and data information analysis of leading company.
F. Hoffmann-La Roche
Pfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company
Takeda
Beacon Pharma
Report Includes:
- xx data tables (appendix tables)
- Overview of global ALK Positive Lung Cancer Treatment market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the ALK Positive Lung Cancer Treatment market
- Profiles of major players in the industry, including F. Hoffmann-La Roche, Pfizer, Novartis, TP Therapeutics, Bristol-Myers Squibb..
Research Objectives
1.To study and analyze the global ALK Positive Lung Cancer Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of ALK Positive Lung Cancer Treatment market by identifying its various subsegments.
3.Focuses on the key global ALK Positive Lung Cancer Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the ALK Positive Lung Cancer Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of ALK Positive Lung Cancer Treatment submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global ALK Positive Lung Cancer Treatment Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 ALK Positive Lung Cancer Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 ALK Positive Lung Cancer Treatment Segment by Type
2.1.1 Crizotinib
2.1.2 Alectinib
2.1.3 Ceritinib
2.1.4 Brigatinib
2.1.5 Other
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinics
2.2.3 Other
2.3 Global ALK Positive Lung Cancer Treatment Market Comparison by Regions (2016-2026)
2.3.1 Global ALK Positive Lung Cancer Treatment Market Size (2016-2026)
2.3.2 North America ALK Positive Lung Cancer Treatment Status and Prospect (2016-2026)
2.3.3 Europe ALK Positive Lung Cancer Treatment Status and Prospect (2016-2026)
2.3.4 China ALK Positive Lung Cancer Treatment Status and Prospect (2016-2026)
2.3.5 Japan ALK Positive Lung Cancer Treatment Status and Prospect (2016-2026)
2.3.6 Southeast Asia ALK Positive Lung Cancer Treatment Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): ALK Positive Lung Cancer Treatment Industry Impact
2.5.1 ALK Positive Lung Cancer Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and ALK Positive Lung Cancer Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global ALK Positive Lung Cancer Treatment Sales and Market Share by Manufacturer (2016-2021)
3.2 Global ALK Positive Lung Cancer Treatment Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global ALK Positive Lung Cancer Treatment Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 ALK Positive Lung Cancer Treatment Manufacturer Market Share
3.5 Top 10 ALK Positive Lung Cancer Treatment Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into ALK Positive Lung Cancer Treatment Market
3.7 Key Manufacturers ALK Positive Lung Cancer Treatment Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of ALK Positive Lung Cancer Treatment Industry Key Manufacturers
4.1 F. Hoffmann-La Roche
4.1.1 Compan Detail
4.1.2 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification
4.1.3 F. Hoffmann-La Roche 130 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 F. Hoffmann-La Roche News
4.2 Pfizer
4.2.1 Compan Detail
4.2.2 Pfizer ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification
4.2.3 Pfizer ALK Positive Lung Cancer Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 F. Hoffmann-La Roche News
4.3 Novartis
4.3.1 Compan Detail
4.3.2 Novartis ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification
4.3.3 Novartis ALK Positive Lung Cancer Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Novartis News
4.4 TP Therapeutics
4.4.1 Compan Detail
4.4.2 TP Therapeutics ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification
4.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 TP Therapeutics News
4.5 Bristol-Myers Squibb
4.5.1 Compan Detail
4.5.2 TP Therapeutics ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification
4.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Bristol-Myers Squibb News
4.6 Eli Lilly and Company
4.6.1 Compan Detail
4.6.2 Eli Lilly and Company ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification
4.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Eli Lilly and Company News
4.7 Takeda
4.7.1 Compan Detail
4.7.2 Takeda ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification
4.7.3 Takeda ALK Positive Lung Cancer Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Beacon Pharma
4.8.1 Compan Detail
4.8.2 Beacon Pharma ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification
4.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Beacon Pharma News
5 Global ALK Positive Lung Cancer Treatment Market Segment by Big Type
5.1 Global ALK Positive Lung Cancer Treatment Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global ALK Positive Lung Cancer Treatment Sales and Market Share by Big Type (2016-2021)
5.1.2 Global ALK Positive Lung Cancer Treatment Revenue and Market Share by Big Type (2016-2021)
5.2 Crizotinib Sales Growth Rate and Price
5.2.1 Global Crizotinib Sales Growth Rate (2016-2021)
5.2.2 Global Crizotinib Price (2016-2021)
5.3 Alectinib Sales Growth Rate and Price
5.3.1 Global Alectinib Sales Growth Rate (2016-2021)
5.3.2 Global Alectinib Price (2016-2021)
5.4 Ceritinib Sales Growth Rate and Price
5.4.1 Global Ceritinib Sales Growth Rate (2016-2021)
5.4.2 Global Ceritinib Price (2016-2021)
5.5 Brigatinib Sales Growth Rate and Price
5.5.1 Global Brigatinib Sales Growth Rate (2016-2021)
5.5.2 Global Brigatinib Price (2016-2021)
5.6 Other Sales Growth Rate and Price
5.6.1 Global Other Sales Growth Rate (2016-2021)
5.6.2 Global Other Price (2016-2021)
6 Global ALK Positive Lung Cancer Treatment Market Segment by Big Application
6.1 Global ALK Positive Lung Cancer Treatment Sales Market Share by Big Application (2016-2021)
6.2 Hospital Sales Growth Rate (2016-2021)
6.3 Clinics Sales Growth Rate (2016-2021)
6.4 Other Sales Growth Rate (2016-2021)
7 Global ALK Positive Lung Cancer Treatment Forecast
7.1 Global ALK Positive Lung Cancer Treatment Revenue, Sales and Growth Rate (2021-2026)
7.2 ALK Positive Lung Cancer Treatment Market Forecast by Regions (2021-2026)
7.2.1 North America ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
7.2.2 Europe ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
7.2.3 China ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
7.2.4 Japan ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
7.2.5 Southeast Asia ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
7.2.6 Other Regions ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
7.3 ALK Positive Lung Cancer Treatment Market Forecast by Type (2021-2026)
7.3.1 Global ALK Positive Lung Cancer Treatment Sales Forecast by Type (2021-2026)
7.3.2 Global ALK Positive Lung Cancer Treatment Market Share Forecast by Type (2021-2026)
7.4 ALK Positive Lung Cancer Treatment Market Forecast by Application (2021-2026)
7.4.1 Global ALK Positive Lung Cancer Treatment Sales Forecast by Application (2021-2026)
7.4.2 Global ALK Positive Lung Cancer Treatment Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 ALK Positive Lung Cancer Treatment Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 ALK Positive Lung Cancer Treatment Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture ALK Positive Lung Cancer Treatment
Figure Market Concentration Ratio and Market Maturity Analysis of ALK Positive Lung Cancer Treatment
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global ALK Positive Lung Cancer Treatment Market Size by Big Type
Figure Global Market Share of ALK Positive Lung Cancer Treatment by Big Type in 2020
Figure Crizotinib Picture (2016-2021)
Figure Alectinib Picture (2016-2021)
Figure Ceritinib Picture (2016-2021)
Figure Brigatinib Picture (2016-2021)
Global ALK Positive Lung Cancer Treatment Market Size by Big Application
Table Global ALK Positive Lung Cancer Treatment Market Size by Application
Figure Global ALK Positive Lung Cancer Treatment Market Share by Big Application in 2020
Figure Hospital Picture
Figure Clinics Picture
Figure Other Picture
Table Global ALK Positive Lung Cancer Treatment Comparison by Regions (M USD) ?2016-2026?
Figure Global ALK Positive Lung Cancer Treatment Market Size (Million US$) (2016-2026)
Figure North America ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure China ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and ALK Positive Lung Cancer Treatment Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global ALK Positive Lung Cancer Treatment Sales by Manufacturer (2016-2021)
Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Manufacturer in 2020
Table Global ALK Positive Lung Cancer Treatment Revenue by Manufacturer (2016-2021)
Figure Global ALK Positive Lung Cancer Treatment Revenue Market Share by Manufacturer in 2020
Table Global ALK Positive Lung Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 ALK Positive Lung Cancer Treatment Manufacturer (Revenue) Market Share in 2020
Figure Top 10 ALK Positive Lung Cancer Treatment Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into ALK Positive Lung Cancer Treatment Market
Table Key Manufacturers ALK Positive Lung Cancer Treatment Product Type
Table Mergers & Acquisitions Planning
Table F. Hoffmann-La Roche Company Profile
Table ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification of F. Hoffmann-La Roche
Table ALK Positive Lung Cancer Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Pfizer Company Profile
Table ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification of Pfizer
Table ALK Positive Lung Cancer Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Pfizer Recent Development
Table Novartis Company Profile
Table ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification of Novartis
Table ALK Positive Lung Cancer Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Novartis Main Business
Table Novartis Recent Development
Table TP Therapeutics Company Profile
Table ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification of TP Therapeutics
Table ALK Positive Lung Cancer Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table TP Therapeutics Main Business
Table TP Therapeutics Recent Development
Table TP Therapeutics Main Business
Table TP Therapeutics Recent Development
Table Bristol-Myers Squibb Company Profile
Table ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification of Bristol-Myers Squibb
Table ALK Positive Lung Cancer Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly and Company Company Profile
Table ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification of Eli Lilly and Company
Table ALK Positive Lung Cancer Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Eli Lilly and Company Main Business
Table Eli Lilly and Company Recent Development
Table Takeda Company Profile
Table ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification of Takeda
Table ALK Positive Lung Cancer Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Takeda Main Business
Table Takeda Recent Development
Table Beacon Pharma Company Profile
Table ALK Positive Lung Cancer Treatment Product Introduction, Application and Specification of Beacon Pharma
Table ALK Positive Lung Cancer Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Beacon Pharma Main Business
Table Beacon Pharma Recent Development
Figure Global ALK Positive Lung Cancer Treatment Sales and Growth Rate (2016-2021)
Figure Global ALK Positive Lung Cancer Treatment Revenue and Growth Rate (2016-2021)
Table Global ALK Positive Lung Cancer Treatment Sales by Regions (2016-2021)
Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Regions in 2020
Table Global ALK Positive Lung Cancer Treatment Revenue by Regions (2016-2021)
Figure Global ALK Positive Lung Cancer Treatment Revenue Market Share by Regions in 2020
Figure North America ALK Positive Lung Cancer Treatment Sales and Growth Rate (2016-2021)
Figure Europe ALK Positive Lung Cancer Treatment Sales and Growth Rate (2016-2021)
Figure China ALK Positive Lung Cancer Treatment Sales and Growth Rate (2016-2021)
Figure Japan ALK Positive Lung Cancer Treatment Sales and Growth Rate (2016-2021)
Figure Southeast Asia ALK Positive Lung Cancer Treatment Sales and Growth Rate (2016-2021)
Figure Other Regions ALK Positive Lung Cancer Treatment Sales and Growth Rate (2016-2021)
Table Global ALK Positive Lung Cancer Treatment Sales by Big Type (2016-2021)
Table Global ALK Positive Lung Cancer Treatment Sales Market Share by Big Type (2016-2021)
Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Big Type in 2019
Table Global ALK Positive Lung Cancer Treatment Revenue by Big Type (2016-2021)
Table Global ALK Positive Lung Cancer Treatment Revenue Market Share by Big Type (2016-2021)
Table Global ALK Positive Lung Cancer Treatment Revenue Market Share by Big Type in 2019
Figure Global Crizotinib Sales Growth Rate (2016-2021)
Figure Global Crizotinib Price (2016-2021)
Figure Global Alectinib Sales Growth Rate (2016-2021)
Figure Global Alectinib Price (2016-2021)
Figure Global Ceritinib Sales Growth Rate (2016-2021)
Figure Global Ceritinib Price (2016-2021)
Figure Global Brigatinib Sales Growth Rate (2016-2021)
Figure Global Brigatinib Price (2016-2021)
Table Global ALK Positive Lung Cancer Treatment Sales by Big Application (2016-2021)
Table Global ALK Positive Lung Cancer Treatment Sales Market Share by Big Application (2016-2021)
Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2016-2021)
Figure Global Clinics Sales Growth Rate (2016-2021)
Figure Global Other Sales Growth Rate (2016-2021)
Figure Global ALK Positive Lung Cancer Treatment Sales and Growth Rate (2021-2026)
Figure Global ALK Positive Lung Cancer Treatment Revenue and Growth Rate (2021-2026)
Table Global ALK Positive Lung Cancer Treatment Sales Forecast by Regions (2021-2026)
Table Global ALK Positive Lung Cancer Treatment Market Share Forecast by Regions (2021-2026)
Figure North America Sales ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
Figure Europe Sales ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
Figure China Sales ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
Figure Japan Sales ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
Figure Southeast Asia Sales ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
Figure Other Regions Sales ALK Positive Lung Cancer Treatment Market Forecast (2021-2026)
Table Global ALK Positive Lung Cancer Treatment Sales Forecast by Type (2021-2026)
Table Global ALK Positive Lung Cancer Treatment Market Share Forecast by Type (2021-2026)
Table Global ALK Positive Lung Cancer Treatment Sales Forecast by Application (2021-2026)
Table Global ALK Positive Lung Cancer Treatment Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of ALK Positive Lung Cancer Treatment
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America ALK Positive Lung Cancer Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe ALK Positive Lung Cancer Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan ALK Positive Lung Cancer Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China ALK Positive Lung Cancer Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
F. Hoffmann-La Roche
Pfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company